Detailed explanation of the efficacy and role of tilorisen (Huacosi), and how effective it is in treating narcolepsy

Pitolisant is a new type of oral central nervous system drug, which is a histamine H3 receptor antagonist/inverse agonist and is mainly used to improve the central arousal state. By blocking the autoinhibitory effect of H3 receptors, it increases the release of histamine in the central nervous system of the brain, thereby enhancing arousal and attention, while regulating neurotransmitter networks, helping to improve sleepiness and cognitive function. The mechanism of tilorisen is unique. Unlike traditional stimulants, it does not directly act on dopamine or epinephrine pathways, so the risk of addiction is low.

The efficacy of tilolixen in the treatment of narcolepsy (Narcolepsy) has been demonstrated in multiple clinical trials. Patients with narcolepsy often present with excessive daytime sleepiness, cataplexy, and disrupted nighttime sleep. Tilorisen can effectively relieve symptoms of daytime sleepiness by enhancing histaminergic nerve activity in the brain, improving wakefulness. Clinical data show that patients treated with tilorisen experienced significant improvements in Epworth Sleepiness Scale (ESS) scores, increased daytime wakefulness, and decreased cataplexy frequency.

The use of tilorisen has also been shown to be well tolerated and safe. Common adverse reactions include headache, insomnia, nausea and mild anxiety, most of which are mild to moderate and can be relieved by themselves or controlled through dose adjustment. Compared with traditional central stimulants such as modafinil or methylphenidate, tilolixan has low addictive properties in long-term use and has less impact on the cardiovascular system, so it is suitable for long-term maintenance treatment. Patients still need to be followed up regularly during medication to monitor the improvement of sleep structure and cognitive function.

In general, tilolixen increases the level of central arousal through a unique histamineH3 receptor mechanism, and has a significant improvement effect on the daytime sleepiness symptoms of narcolepsy. It has stable efficacy and good tolerance, and can be an important drug choice for the daily management of narcolepsy patients. For some patients with cataplexy or nighttime sleep disorders, it can be used in combination with other drugs to develop an individualized treatment plan to obtain the best therapeutic effect.

Reference materials:https://www.drugs.com/